Advertisement

Topics

CytoBioScience Plans Merger With Publicly Traded Skyline Medical

16:49 EDT 1 Aug 2017 | Xconomy

San Antonio — CytoBioScience, a startup that sells a device used to screen drug formulations, has plans to merge with a Minnesota-based medical device maker that’s traded on the Nasdaq market for companies with smaller market capitalizations. CytoBioScience announced today it signed a letter of intent to merge with Eagan, MN-based Skyline Medical (NASDAQ: SKLN), […]

Original Article: CytoBioScience Plans Merger With Publicly Traded Skyline Medical

NEXT ARTICLE

More From BioPortfolio on "CytoBioScience Plans Merger With Publicly Traded Skyline Medical"

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...